您好,欢迎光临世界标品! 登录 注册(订药物标准品请用邮件联系我们)

SCITEK INTERNATIONAL (H.K.) LIMITED
Email: sciteck.hongkong@gmail.com
 

当前本网站药物产品种数共 8524 处方药 8148 非处方药 269 保健品/医疗用具 107

世界标品医药目录搜索(中英文):
世界各国官方药品目录搜索(英文):
世界标品医药知识搜索(中英文):

联系方式
国内客服电话:
国际免费电话:

咨询邮箱:
scimed.shanghai@shijiebiaopin.com
info@shijiebiaopin.com
pharmacy.shijiebiaopin1@gmail.com
pharmacy.shijiebiaopin2@gmail.com

  药店国别: 日本药房
产地国家: 日本
所属类别: 影响血液及造血系统药物->坏血病
处方药:处方药
包装规格: 2.5微克 14片/盒
计价单位:
   
生产厂家英文名:
Torii
该药品相关信息网址1:
http://www.toray.com/news/medical/nr090323.html
该药品相关信息网址2:
http://www.rad-ar.or.jp/siori/english/kekka.cgi?n=1605
原产地英文商品名:
REMITCH OD 2.5mcg 14 Tablets
原产地英文药品名:
Nalfurafine hydrochloride
中文参考商品译名:
REMITCH OD 2.5微克 14片/盒
中文参考药品译名:
盐酸纳呋拉啡
原产地国家批准上市年份:
0000/00/00
英文适应病症1:
Improvement of pruritus in hemodialysis patients
临床试验期:
完成
中文适应病症参考翻译1:
改善血液透析患者瘙痒
药品信息:
Toray Industries, Inc. (Head Office: Chuo-ku, Tokyo; President: Sadayuki Sakakibara; “Toray”); Japan Tobacco Inc. (Head Office: Minato-ku, Tokyo; President: Hiroshi Kimura); and Torii Pharmaceutical Co., Ltd. (Head Office: Chuo-ku, Tokyo; President: Norihiko Matsuo; “Torii”) hereby announced that Torii would launch REMITCH® CAPSULES 2.5 μg (generic name: nalfurafine hydrochloride), an oral antipruritus drug for hemodialysis patients , starting March 24. It was jointly developed by the three companies and its manufacturing and marketing approval was obtained in Japan by Toray on January 21, 2009. Hemodialysis-related uremic pruritus is a condition that causes systemic and severe itching without inflammation on the skin and its cause has yet been clearly elucidated. It is known that this type of itching is not relieved by conventional antipruritus drugs (such as antihistamines) and the development of effective medicines has long been awaited. REMITCH® CAPSULES 2.5 μg is a selective κ (kappa)-opioid receptor agonist, originated from Toray, Japan for the first time as an oral drug to treat itching in hemodialysis patients that is resistant to existing treatments. This drug is expected to make further contribution to the treatment of pruritus in hemodialysis patients. Following is the outlines of REMITCH® CAPSULES 2.5 μg. Notes Brand name : REMITCH® CAPSULES 2.5 μg Generic name : Nalfurafine hydrochloride Indication : Improvement of pruritus in hemodialysis patients (only for cases resistant to conventional treatments) Dosage and administration : The usual oral dosage for adults is 2.5 μg of nalfurafine hydrochloride, once a day, after supper or before sleep. The dosage may be adjusted according to symptoms provided that it does not exceed 5 μg once a day.
更新日期: 2018-09-05
附件:
 
调控比例: 100%
订购表单下载
Copyrights © 2010,2011,2012 www.ShiJieBiaoPin.com, Inc., All rights Reserved www.ShiJieBiaoPin.com, Inc.
客服工作时间:太平洋时间18:00-24:00
国内客服电话:     国际免费电话:
友情提示:以上电话为免费电话,无需您承担任何费用,世界标品提供中文客服,请您放心拨打!
电子邮箱:sciteck.hongkong@gmail.com, 15901965168@163.com